{"title":"[很少有人在脆性骨折后接受初级保健治疗]。","authors":"Jacob Fricke, Stina Ek, Karin Modig","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>We investigated how many of first-time fragility fracture patients were followed up in primary care and treated with bone-specific drugs. By combining data from multiple health data registers, we included 11,102 patients aged 60 years or older who sustained a fragility fracture in Region Stockholm between January 1, 2021, and June 30, 2022. The follow-up period extended up to 6 months after the fracture. Follow-up was defined as a visit to a primary care physician together with one of the following: 1) osteoporosis diagnosis, 2) bone-specific drug treatment or 3) dual-energy X-ray absorptiometry. Our findings revealed that less than 1 out of 5 patients were followed up in primary care after their first fragility fracture. Follow-up was more common among women, older patients, and for central fractures (hip, pelvis, lumbar spine). Moreover, just over 5% received bone-specific drugs within 6 months.</p>","PeriodicalId":17988,"journal":{"name":"Lakartidningen","volume":"122 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Few are treated in primary care after a fragility fracture].\",\"authors\":\"Jacob Fricke, Stina Ek, Karin Modig\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We investigated how many of first-time fragility fracture patients were followed up in primary care and treated with bone-specific drugs. By combining data from multiple health data registers, we included 11,102 patients aged 60 years or older who sustained a fragility fracture in Region Stockholm between January 1, 2021, and June 30, 2022. The follow-up period extended up to 6 months after the fracture. Follow-up was defined as a visit to a primary care physician together with one of the following: 1) osteoporosis diagnosis, 2) bone-specific drug treatment or 3) dual-energy X-ray absorptiometry. Our findings revealed that less than 1 out of 5 patients were followed up in primary care after their first fragility fracture. Follow-up was more common among women, older patients, and for central fractures (hip, pelvis, lumbar spine). Moreover, just over 5% received bone-specific drugs within 6 months.</p>\",\"PeriodicalId\":17988,\"journal\":{\"name\":\"Lakartidningen\",\"volume\":\"122 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-10-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lakartidningen\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lakartidningen","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Few are treated in primary care after a fragility fracture].
We investigated how many of first-time fragility fracture patients were followed up in primary care and treated with bone-specific drugs. By combining data from multiple health data registers, we included 11,102 patients aged 60 years or older who sustained a fragility fracture in Region Stockholm between January 1, 2021, and June 30, 2022. The follow-up period extended up to 6 months after the fracture. Follow-up was defined as a visit to a primary care physician together with one of the following: 1) osteoporosis diagnosis, 2) bone-specific drug treatment or 3) dual-energy X-ray absorptiometry. Our findings revealed that less than 1 out of 5 patients were followed up in primary care after their first fragility fracture. Follow-up was more common among women, older patients, and for central fractures (hip, pelvis, lumbar spine). Moreover, just over 5% received bone-specific drugs within 6 months.